Edition:
India

Equillium Inc (EQ.OQ)

EQ.OQ on NASDAQ Stock Exchange Global Market

3.76USD
1:30am IST
Change (% chg)

$0.08 (+2.17%)
Prev Close
$3.68
Open
$3.78
Day's High
$3.89
Day's Low
$3.67
Volume
1,678
Avg. Vol
8,762
52-wk High
$19.53
52-wk Low
$3.12

Latest Key Developments (Source: Significant Developments)

Equillium Says Q2 Loss Per Share of $0.35
Tuesday, 13 Aug 2019 

Aug 12 (Reuters) - Equillium Inc ::EQUILLIUM REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND RECENT HIGHLIGHTS.Q2 LOSS PER SHARE $0.35.Q2 EARNINGS PER SHARE ESTIMATE $-0.34 -- REFINITIV IBES DATA.  Full Article

Victory Capital Management Inc Reports 11.79% Passive Stake In Equillium Inc
Monday, 5 Aug 2019 

Aug 5 (Reuters) - Equillium Inc ::VICTORY CAPITAL MANAGEMENT INC REPORTS 11.79% PASSIVE STAKE IN EQUILLIUM INC AS OF JULY 31 - SEC FILING.  Full Article

Equillium Reports Q1 Loss Per Share $0.34
Tuesday, 14 May 2019 

May 13 (Reuters) - Equillium Inc ::EQUILLIUM REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND RECENT HIGHLIGHTS.Q1 LOSS PER SHARE $0.34.ON TRACK TO INITIATE PHASE 1B PROOF-OF-CONCEPT TRIALS OF ITOLIZUMAB (EQ001) IN UNCONTROLLED ASTHMA AND LUPUS NEPHRITIS THIS YEAR.  Full Article

Equillium Reports Q4, FY18 Results
Thursday, 28 Mar 2019 

March 27 (Reuters) - Equillium Inc ::EQUILLIUM REPORTS FOURTH QUARTER AND FULL-YEAR 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS.EQUILLIUM INC - QTRLY LOSS PER SHARE $0.31.  Full Article

Equillium Granted U.S. FDA Fast Track Designation For EQ001
Wednesday, 19 Dec 2018 

Dec 19 (Reuters) - Equillium Inc ::EQUILLIUM GRANTED U.S. FDA FAST TRACK DESIGNATION FOR EQ001 FOR THE TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE.EQUILLIUM INC - COMPANY IS PLANNING TO INITIATE A PHASE 1B/2 CLINICAL TRIAL IN EARLY 2019.EQUILLIUM INC - COMPANY IS PLANNING TO INITIATE A PHASE 1B/2 CLINICAL TRIAL IN EARLY 2019.  Full Article

Equillium Announces Pricing Of Initial Public Offering
Friday, 12 Oct 2018 

Oct 12 (Reuters) - Equillium Inc ::EQUILLIUM ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.EQUILLIUM INC - PRICING OF ITS INITIAL PUBLIC OFFERING OF 4.7 MILLION SHARES OF COMMON STOCK AT $14.00 PER SHARE.  Full Article

India's Lakshmi Vilas Bank Appoints Srinath As Chief Risk Officer
Wednesday, 27 Jun 2018 

June 27 (Reuters) - Lakshmi Vilas Bank Ltd ::APPOINTS SRINATH AS CHIEF RISK OFFICER.  Full Article

Lakshmi Vilas Bank Says News Item About Co In Talks To Sell Stake Is Incorrect
Monday, 28 May 2018 

May 28 (Reuters) - Lakshmi Vilas Bank Ltd ::CLARIFIES ON NEWS ITEM THAT SAID CO IN TALKS WITH BANKS, PE FUNDS TO SELL UP TO 26 PERCENT STAKE.NEWS ITEM IS FACTUALLY INCORRECT; BANK NOT INTO ANY NEGOTIATION WITH ANY SPECIFIC INVESTOR FOR THE PARTICULAR CAPITAL RAISE.  Full Article

Lakshmi Vilas Bank CFO ‍N S Venkatesh resigns​
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Lakshmi Vilas Bank Ltd ::Says ‍N S Venkatesh, executive director & chief financial officer resigns​.  Full Article

Lakshmi Vilas Bank says NIM as of Sept 30 stood at 2.83 pct
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Lakshmi Vilas Bank Ltd :Says NIM of bank stood at 2.83 percent as of sept 30 versus 2.78 percent last yr‍​.Says consequent on slippages in quarter, watchlist now stands at about INR 17 bln‍​‍​.Slippages during quarter were almost entirely from watch list account; same is reflected in provisions.  Full Article